Greg Pyszczymuka

Corporate Officer/Principal bij AYTU BIOPHARMA, INC.

Vermogen: 71 719 $ op 31-05-2024

Health Technology

Consumer Services

Actieve functies van Greg Pyszczymuka

Bedrijven	Functie	Begin	Einde
AYTU BIOPHARMA, INC.	Corporate Officer/Principal	01-01-2022	-

Bedrijven	Functie	Begin	Einde
NEOS THERAPEUTICS, INC.	Corporate Officer/Principal	01-11-2018	31-03-2021

Rutgers State University of New Jersey	Undergraduate Degree
Argosy University	Masters Business Admin

Internationaal

Verenigde Staten

Operationeel

Corporate Officer/Principal	2
Undergraduate Degree	1
Masters Business Admin	1

Sectoraal

Health Technology	3
Consumer Services	3

Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Beursgenoteerde bedrijven	1
AYTU BIOPHARMA, INC.	Health Technology

Bedrijven in privébezit	1
Neos Therapeutics, Inc. Neos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Neos Therapeutics, Inc is a pharmaceutical company focused on developing, manufacturing and commercializing products utilizing its proprietary modified-release drug delivery technology platforms. Its products are Adzenys XR-ODT (amphetamine), Cotempla XR-ODT (methylphenidate), and Adzenys-ER (amphetamine) extended-release oral suspension, all for the treatment of ADHD, are the first three approved products using the Company's extended-release technology platform. The firm manufactures and markets its generic version of the branded product Tussionex, an extended-release oral suspension of hydrocodone and chlorpheniramine for the relief of cough and upper respiratory symptoms of a cold. The company was founded by Darlene R. Ryan on November 30, 1994 and is headquartered in Grand Prairie, TX.	Health Technology

Bedrijven in privébezit

Health Technology